1. Home
  2. IRD vs DSWL Comparison

IRD vs DSWL Comparison

Compare IRD & DSWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • DSWL
  • Stock Information
  • Founded
  • IRD 2018
  • DSWL 1987
  • Country
  • IRD United States
  • DSWL Macau
  • Employees
  • IRD N/A
  • DSWL N/A
  • Industry
  • IRD
  • DSWL Plastic Products
  • Sector
  • IRD
  • DSWL Industrials
  • Exchange
  • IRD NYSE
  • DSWL Nasdaq
  • Market Cap
  • IRD 36.1M
  • DSWL 42.5M
  • IPO Year
  • IRD N/A
  • DSWL 1995
  • Fundamental
  • Price
  • IRD $1.13
  • DSWL $2.36
  • Analyst Decision
  • IRD Strong Buy
  • DSWL
  • Analyst Count
  • IRD 1
  • DSWL 0
  • Target Price
  • IRD $8.00
  • DSWL N/A
  • AVG Volume (30 Days)
  • IRD 159.2K
  • DSWL 7.7K
  • Earning Date
  • IRD 02-15-2025
  • DSWL 11-15-2024
  • Dividend Yield
  • IRD N/A
  • DSWL 8.44%
  • EPS Growth
  • IRD N/A
  • DSWL 69.42
  • EPS
  • IRD N/A
  • DSWL 0.65
  • Revenue
  • IRD $8,381,000.00
  • DSWL $66,813,999.00
  • Revenue This Year
  • IRD N/A
  • DSWL N/A
  • Revenue Next Year
  • IRD $29.37
  • DSWL N/A
  • P/E Ratio
  • IRD N/A
  • DSWL $3.68
  • Revenue Growth
  • IRD N/A
  • DSWL N/A
  • 52 Week Low
  • IRD $0.81
  • DSWL $2.14
  • 52 Week High
  • IRD $2.77
  • DSWL $2.74
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • DSWL 41.36
  • Support Level
  • IRD N/A
  • DSWL $2.30
  • Resistance Level
  • IRD N/A
  • DSWL $2.42
  • Average True Range (ATR)
  • IRD 0.00
  • DSWL 0.03
  • MACD
  • IRD 0.00
  • DSWL 0.00
  • Stochastic Oscillator
  • IRD 0.00
  • DSWL 33.33

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

Share on Social Networks: